Peptide-enhanced oral delivery of therapeutic peptides and proteins

    9 Citationer (Scopus)

    Abstract

    Systemic therapy upon oral delivery of biologies, such as peptide and protein drugs is limited due to their large molecular size, their low enzymatic stability and their inability to cross the intestinal epithelium. Ways to overcome the epithelial barrier include the use of peptide-based excipients such as the cell penetrating peptides (CPPs) and the tight junction modulating peptides (TJMPs), which are able to translocate across the cellular membranes in a non-disruptive way or reversibly modulate the integrity of intercellular tight junctions (TJs), respectively. However, because of the harsh environment throughout the gastrointestinal (GI) tract, chemical stability is an inherent challenge when employing amino acid-based excipients for oral delivery, and multiple approaches have been investigated to improve this. The exact mechanisms of transepithelial translocation are discussed, and it is believed that CPP-mediated translocation involves transcytosis and/or direct translocation through the epithelial cells; whereas TJMP-mediated translocation is dependent on interaction with transmembrane or peripheral TJ proteins. This review focuses on the CPPs and the TJMPs currently employed as excipients for oral delivery of peptide and protein drugs highlighting recent studies and the most promising compounds from these classes of peptide excipients.

    OriginalsprogEngelsk
    TidsskriftJournal of Drug Delivery Science and Technology
    Vol/bind23
    Udgave nummer4
    Sider (fra-til)365-373
    Antal sider9
    ISSN1773-2247
    StatusUdgivet - 2013

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Peptide-enhanced oral delivery of therapeutic peptides and proteins'. Sammen danner de et unikt fingeraftryk.

    Citationsformater